Herbert Kuhl

No ORCID on file · 10 papers in corpus
rct 2011
Contraception ·doi:10.1016/j.contraception.2011.01.002

BACKGROUND: The present study compared the efficacy and safety of a combined oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest (EE/DNG) in conventional and extended-cycle regimen over 1 year of treatment. STUDY DESIG…

observational 2010
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.3109/13625187.2010.518708

OBJECTIVES: To investigate prescribing preferences and personal experience of female gynaecologists with extended-cycle use of combined oral contraceptives (COCs) in Germany and Austria. METHODS: A questionnaire on prescribing patterns and…

review 2009
Therapeutische Umschau. Revue therapeutique ·doi:10.1024/0040-5930.66.2.129

A non-contraceptive benefit of oral hormonal contraceptives (OC) is a diminished risk for certain benign as well as malignant tumours, such as benign breast tumours, uterine fibroids and ovarian cysts. Endometriosis itself is not positively…

rct 2009
Contraception ·doi:10.1016/j.contraception.2009.07.011

BACKGROUND: The effects of extended regimens of combined oral contraceptives (COC) on lipid parameters are largely unknown. The present study compared the effects of a COC containing 30 mcg ethinyl estradiol and 2 mg dienogest (EE/DNG) in c…

review 2009
Therapeutische Umschau. Revue therapeutique ·doi:10.1024/0040-5930.66.2.101

Surveys show that most women desire a change in their menstrual pattern in the sense that they would prefer less menstruations or even amenorrhea. On this behalf, there is no difference between women having spontaneous natural cycles and wo…

rct 2008
Contraception ·doi:10.1016/j.contraception.2008.02.005

BACKGROUND: This study was conducted to investigate the effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters. STUDY DESIGN: Thyroid and androgen parameters were…

rct 2008
Contraception ·doi:10.1016/j.contraception.2008.06.015

BACKGROUND: The study was conducted to investigate the effect of a combined oral contraceptive (COC) containing 30 mcg ethinylestradiol and 2 mg dienogest with two different regimens on various hemostasis variables. STUDY DESIGN: Hemostati…

review 2006
Women's health (London, England) ·doi:10.2217/17455057.2.5.705

During the use of long-cycle regimens of monophasic oral contraceptives, the total number of bleeding and cycle-dependent complaints is considerably lower than during conventional treatment with oral contraceptives. Despite an initially hig…

nonrandomized-trial 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2005.11.052

OBJECTIVE: To examine the conception rate after cessation of a combination of 30 microg ethinyl E2 and 2 mg dienogest (EE/DNG). DESIGN: Prospective observational study. SETTING: Population-based cohort in Germany. PATIENT(S): Women who w…

review 2004
Drugs ·doi:10.2165/00003495-200464210-00006

The conventional regimen of oral contraceptive (OC) use mimics the natural cycles by causing regular withdrawal bleeding, which can be avoided by omission of the hormone-free interval of 7 days. Consequently, long-cycle regimens with contin…